Tyler Van Buren is a vice president covering specialty pharmaceutical companies. Prior to joining Cowen in 2013, Mr. Van Buren was a founding member and managing director at LifeSci Advisors, where he covered small- to mid-cap companies primarily in the biotechnology space. Previously, he was a project management consultant for Lithera Pharmaceuticals (now Neothetics) and before that, he was in alliance management at Amylin Pharmaceuticals (later acquired by Bristol-Myers Squibb and AstraZeneca). Mr. Van Buren has a bachelor of science degree in biochemistry and cellular biology and completed a research-based masters of science degree in stem cell biology from the University of California, San Diego.
TylerVan Buren, M.Sc.
Vice President, Health Care - Pharmaceuticals/Specialty
599 Lexington Avenue
New York, NY 10022
D 646 562 1338